R. Scott Struthers's Insider Trades & SAST Disclosures
R. Scott Struthers's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 16,463 Common Stock done at an average price of $34.2 . Disclosure was reported to the exchange on March 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. Scott Struthers.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 34.17 per share. | 19 Mar 2025 | 16,463 | 330,022 (1%) | 0% | 34.2 | 562,541 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 34.83 per share. | 19 Mar 2025 | 875 | 329,147 (1%) | 0% | 34.8 | 30,476 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 313,000 | 313,000 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 89,000 | 346,485 (1%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Struthers R. Scott | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.57 per share. | 02 Dec 2024 | 10,000 | 100,000 (0%) | 0% | 57.6 | 575,700 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.28 per share. | 08 May 2024 | 107,448 | 364,933 (1%) | 0% | 9.3 | 997,117 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 107,448 | 16,342 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 49.40 per share. | 08 May 2024 | 107,448 | 257,485 (1%) | 0% | 49.4 | 5,307,931 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Apr 2024 | 350 | 257,485 (1%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 15 Apr 2024 | 20,000 | 257,835 (1%) | 0% | 1.9 | 38,200 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 20,000 | 81,270 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.28 per share. | 04 Apr 2024 | 40,951 | 278,786 (1%) | 0% | 9.3 | 380,025 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 40,951 | 123,790 | - | - | Non-qualified stock option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 49.17 per share. | 04 Apr 2024 | 40,951 | 237,835 (0%) | 0% | 49.2 | 2,013,561 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.14 per share. | 18 Mar 2024 | 12,687 | 237,835 (0%) | 0% | 38.1 | 483,882 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 250,522 (1%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Scott Struthers R. | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 60,000 | 570,805 (2%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Scott R. Struthers | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 20,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | R. Struthers Scott | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 20,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Struthers Scott R. | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 20,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 10,000 | 151,270 | - | - | Incentve stock option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 14 Aug 2023 | 10,000 | 135,522 (0%) | 0% | 1.9 | 19,100 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 11 Jul 2023 | 24,384 | 656,421 (2%) | 0% | 20.1 | 491,094 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.35 per share. | 11 Jul 2023 | 14,157 | 630,805 (2%) | 0% | 20.4 | 288,095 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.17 per share. | 11 Jul 2023 | 11,459 | 644,962 (2%) | 0% | 20.2 | 231,128 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.81 per share. | 16 Jun 2023 | 50,000 | 680,805 (2%) | 0% | 20.8 | 1,040,500 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.12 per share. | 16 Mar 2023 | 4,628 | 125,522 (0%) | 0% | 17.1 | 79,231 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 287,700 | 287,700 | - | - | Common Stock (right to buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 61,650 | 130,150 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2022 | 11,100 | 161,270 | - | - | Incentive stock option (Right to Buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 12 Oct 2022 | 11,100 | 68,500 (0%) | 0% | 1.9 | 21,201 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 27.53 per share. | 13 Apr 2022 | 69,176 | 730,805 (3%) | 0% | 27.5 | 1,904,256 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 13 Apr 2022 | 44,793 | 799,981 (3%) | 0% | 26.5 | 1,188,040 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 13 Apr 2022 | 24,674 | 844,774 (3%) | 0% | 25.4 | 627,329 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.34 per share. | 05 Apr 2022 | 21,357 | 869,448 (3%) | 0% | 25.3 | 541,225 | Common Stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 249,200 | 249,200 | - | - | Common Stock (right to buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 53,400 | 57,400 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Sep 2021 | 10,000 | 90,000 (0%) | 0% | 25 | 250,000 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Sep 2021 | 10,000 | 90,000 (0%) | 0% | 25 | 250,000 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Sep 2021 | 10,000 | 90,000 (0%) | 0% | 25 | 250,000 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 294,000 | 294,000 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 13.10 per share. | 02 Dec 2020 | 4,000 | 4,000 (0%) | 0% | 13.1 | 52,400 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 12.60 per share. | 02 Dec 2020 | 1,000 | 1,000 (0%) | 0% | 12.6 | 12,600 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 14.46 per share. | 15 Jul 2020 | 17,500 | 890,805 (3%) | 0% | 14.5 | 253,108 | Common stock |
| Crinetics Pharmaceuticals Inc | R. Scott Struthers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 15 Jul 2020 | 17,500 | 908,305 (3%) | 0% | 15.3 | 267,722 | Common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges